ArticleJournal of the American Academy of Dermatology2017

Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure.

Lucy Y Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.